Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target engagement on all key biomarkers in the ...
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Expands Clinical Development of Neuroprotective Therapy
This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum ...
Fi 7 validation with high-density signal distribution, enhanced spatial resolution, and compact RF system integration.
Globally recognized leader in early-phase oncology clinical development and experimental therapeuticsStrengthens strategic ...
An experimental drug repaired the gut and reversed severe fatty liver disease in animals, opening the door to a promising new ...
Xenon nears a Q3 2026 NDA with strong Phase 3 epilepsy data and a cash runway to 2029. Click here to read an analysis of XENE ...
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) was featured in a recent article that discussed its advancement of its ...
Tech Xplore on MSN
Programmable metasurface generates dozens of holograms at once
Over the past few decades, engineers have developed various devices that can create holograms, three-dimensional (3D) or ...
FDA has accepted Bristol Myers Squibb's New Drug Application for mezigdomide in combination with carfilzomib and ...
ASCO 2026 highlighted a shift toward precision-driven oncology R&D, where biomarkers, ctDNA, and integrated strategies guide ...
Vadzo's Falcon-521CRS is a 5MP color USB 3.0 Camera insurance telematics camera built on the Onsemi AR0521 sensor, delivering ...
Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced the initiation of the Phase III clinical trial for Rentosertib, its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results